mata kuliah kekhususan farmakologi-rev13agustus2015

Upload: rozi-abdullah

Post on 23-Feb-2018

219 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/24/2019 Mata Kuliah Kekhususan Farmakologi-rev13Agustus2015

    1/12

    !"#" %&'(") %*+)&,&,"- ."/0"+1'12(

    31 4 %15* !% 3"0" !% 6%6 %11/5(-"#1/

    !% 72"-8('9

    %11/5(-"#1/

    !% 72*-":9

    !"#$%#"& ()*+,*- ./,/) 012,*21314* 5 6*7*/+ 8/9/*:;3*

    !"#$%#"< =/):/21.*+/:*2 & >/?)*/3.* =)/+,

    !"#$%#"@ =/):/212*+A0*2 5 B)* C !A37/

    !"#$%#"% !A01.1314* DE F GH( 5 "A9* IA37*+/ B+44*

    !"#$%#" (A+A:;/+ F -A+4A:J/+4/+ 1J/0 & B)* C !A37/

    !"#$%#"5#& KA2+*2 ./3/: -A+A:;/+ F

    -A+4A:J/+4/+ 1J/0

    & B)* C 8/9/*:;3*

    !"#$%#"&&@ C?A2 ,/:-*+4 ./+ *+0A)/2,* 1J/0 & 6*7*/+ L+,0*/0M

    !"#$%#"&&N ()*+,*- ./,/) A7/3;/,* 1J/0 & 8/9/*:;3* !A37/

    !"#$%#"&&% C7/3;/,* ;+0;2 )A4*,0)/,* 1J/0 & !A37/ "A9* IA37*+/

    !"#$%#"N =/):/214A+1:*2 O & L+,0*/0M !A37/

    !"#$%#"P ()*+,*- ./,/) 0A)/-* /+0*:*2)1J/ O & 8/9/*:;3* B)* C

    !"#$%#"&&P =/):/21314* /+0*:*2)1J/ O & "A9* IA37*+/ Q*/+01

    !"#$%#"R =/):/21314* 1J/0 2/).*17/,2;3A) O 5 8/9/*:;3* =)/+,

    !"#$%#"& SJ/0 TA)J/3 O & 6*7*/+ (;)9/+0M/,0;0*

    !"#$%#"&&< >A;)1?/):/21314* O & 8/9/*:;3* 8/9/*:;3*

    !"#$%#"&&R C+.12)*+1?/):/21314* O & L+,0*/0M "A9* IA37*+/

    !"#$%#"&&$ EA:10A)/-A;0*2 ./+ J*10A)/-A;0*2 O & !A37/ 6*7*/+

    ; :('()"- 5"'"0 +*+)&,&,"- ."/0"+1'12(

  • 7/24/2019 Mata Kuliah Kekhususan Farmakologi-rev13Agustus2015

    2/12

    6*

  • 7/24/2019 Mata Kuliah Kekhususan Farmakologi-rev13Agustus2015

    3/12

    !"#" %&'(") N L/(-,(: 5","/ #1+,(+1'12(

    %15* !% N !" #$%#"&

    6%6 N A

    %11/5(-"#1/ !% N 6*0*,#*/ 2"-8(' N !*'O"

    6*0*,#*/ 2*-": N P"Q"(0&'(

    31 >1:(+ R&0'")

    R"0

    L*-2"8"/

    7,*0 2"-8('9

    L*-2"8"/

    7,*0 2*-":9

    & (A+4/+0/) ./+ -)*+,*- 012,*21314* 5 =)/+, =)/+,

    5 !;0/4A+A,*, ./+ -A:A)*2,//+

    :;0/4A+A,*,

    5 !A37/ B)* C

    @ KA)/014A+A,*, ./+ -A:A)*2,//+

    0A)/014A+A,*,

    5 !A37/ B)* C

    P E/),*+14A+A,*, ./+ -A:A)*2,//+

    2/),*+14A+A,*,

    5 !A37/ B)* C

    < K12,*,*0/, J/T/+ 2*:*/ /2*J/0 2A)U/ ./+

    3*+42;+4/+

    P B)* C B)* C

    R ()*+,*- ./,/) .*/4+1,*, ./+

    -A+4/+44;3/+4/+ 2A)/Z;+/+ /2;0 -/./

    :/+;,*/

    5 =)/+, =)/+,

    $ (A:A)*2,//+ (B ;+0;2 -A:A)*2,//+

    012,*,*0/,

    5 6*7*/+ 8/9/*:;3*

    % K12,*21314* /+/3*0*2 5 B)* C B)* C

    N K12,*,*0/, ,-A,*?*2 1)4/+ 5 6*7*/+ 8/9/*:;3* I0)A, 12,*./0*? ./+ /+0*12,*./+ 5 =)/+, =)/+,

    && (A:A)*2,//+ 012,*,*0/, /2;0 @ =)/+, =)/+,

    &5 (A:A)*2,//+ 012,*,*0/, 2)1+*2 @ =)/+, =)/+,

    &@ DU*/+ L 5 !A37/ 8/9/*:;3*

    &P DU*/+ LL 5 !A37/ 8/9/*:;3*

  • 7/24/2019 Mata Kuliah Kekhususan Farmakologi-rev13Agustus2015

    4/12

    !"#" %&'(") N ."/0"+1+(-*#(+

    E1.A !E [ !" #$%#"@

    6%6 N A

    %11/5(-"#1/ !% N ,*0*,#*/ 2"-8(' N D/( =

    ,*0*,#*/ 2*-": N !*'O"

    31 >1:(+ R&0'")

    R"0

    L*-2"8"/

    7,*0 2"-8('9

    L*-2"8"/

    7,*0 2*-":9

    & K)/+,-1) 1J/0 3*+0/, :A:J)/+ & B)* C !A37/

    5 BJ,1)-,* 5 B+44* "A9* IA37*+/

    @ \*1/7/*3/J*3*0/, ./+ J*1A2*7/3A+,* 5 B+44* "A9* IA37*+/

    P "*,0)*J;,* ./+ *2/0/+ -)10A*+ 5 B)* C !A37/

    < !A0/J13*,:A 1J/0 ./+ 23*)A+, TA-/) P B)* C !A37/

    R C2,2)A,* ./+ 23*)A+, 4*+U/3 @ 6*7*/+ 8/9/*:;3*

    $ (A+4/);T -A+M/2*0 0A)T/./-

    ?/):/212*+A0*2 1J/0

    5 B+44* 8/9/*:;3*

    % (A+4/);T ;,*/ 0A)T/./- ?/):/212*+A0*2

    1J/0

    5 6*7*/+ 8/9/*:;3*

    N (A+MA,;/*/+ .1,*, -/./ 4/4/3 4*+U/3 5 6*7*/+ 8/9/*:;3*

    E*+A0*2/ -1-;3/,* 5 B)* C !A37/

    && =/):/212*+A0*2 23*+*2 5 Q*/+01 Q*/+01

    &5 ]/0*T/+ ,1/3 ?/):/212*+A0*2 23*+*2 P Q*/+01 Q*/+01

    &@ DU*/+ & 5 B)* C !A37/

    &P DU*/+ 5 5 B)* C !A37/

    !"#" %&'(") N ."/0"+15(-"0(+

    %15* !% N !" #$%#":(+ R&0'")

    R"0

    L*-2"8"/

    7,*0 2"-8('9

    L*-2"8"/

    7,*0 2*-":9

    & QA,A-01) P =)/+, =)/+,

    5 ()*+,*- /41+*,X/+0/41+*, 5 =)/+, =)/+,

    @ ^;J;+4/+ .1,*,XA?A2 5 =)/+, =)/+,

    P !A2/+*,:A 0)/+,.;2,* ,*+M/3 @ >/?)*/3.* >/?)*/3.*

    < ^;J;+4/+ ,0);20;)X/20*7*0/, @ !A37/ !A37/

    R DU*/+ 5 >/?)*/3.* =)/+,

  • 7/24/2019 Mata Kuliah Kekhususan Farmakologi-rev13Agustus2015

    5/12

    !"#" %&'(") N L/(-,(: 5","/ #*/":( "-#(0(+/11:(+ R&0'")

    R"0

    L*-2"8"/

    7,*0 2"-8('9

    L*-2"8"/

    7,*0 2*-":9

    & ()*+,*- ;:;: 0A)/-* /+0*:*2)1J/ @ Q*/+01 Q*/+01

    5 (E_(" F !(H

    V!"#$%# '()*)%#+,% -,%-)%#($#+,%W

    @ Q*/+01 Q*/+01

    @ !A2/+*,:A )A,*,0A+,* 5 Q*/+01 >/?)*/3.*

    P .%+!$/ !,0)/ ,1 +%1)-#+,% 1,( 2#"03

    ,1 $%#+!+-(,4+$/ '5$(!$-,03%$!+-2

    5 Q*/+01 >/?)*/3.*

    < 6+,$22$3-10A+,* /+0*:*2)1J/ 5 8/9/*:;3* B)* C

    R !1.A3 +% *+#(,;+0;2 )A,*,0A+,*

    /+0*:*2)1J/

    5 8/9/*:;3* B)* C

    $ DU*/+ 5 8/9/*:;3* B)* C

    !"#" %&'(") N ."/0"+1'12( "-#(0(+/11:(+ R&0'")

    R"0

    L*-2"8"/

    7,*0 2"-8('9

    L*-2"8"/

    7,*0 2*-":9

    & =/):/21314* /+0*J*10*2/ P L+,0*/0M Q*/+01

    5 =/):/21314* /+0*7*);, 5 "A9* IA37*+/ Q*/+01

    @ =/):/21314* /+0*U/:;) 5 "A9* IA37*+/ B)* C

    P =/):/21314* /+0*-/)/,*0

    V:/3/)*/` TA3:*+0T` -)101a1/`

    ?*3/)*/W

    P L+,0*/0M B)* C

    < =/):/21314* /+0*:*21J/20A)* 5 (;)9/+0M/,0;0* (;)9/+0M/,0;0*

    R DU*/+ 5 "A9* IA37*+/ Q*/+01

  • 7/24/2019 Mata Kuliah Kekhususan Farmakologi-rev13Agustus2015

    6/12

  • 7/24/2019 Mata Kuliah Kekhususan Farmakologi-rev13Agustus2015

    7/12

    !"#" %&'(") N L/(-,(: C","/ =O"'&",( 11:(+ R&0'")

    R"0

    L*-2"8"/

    7,*0 2"-8('9

    L*-2"8"/

    7,*0 2*-":9

    & 7,8 #, 5$%0/) ()9+2#($#+,% 0,22+)( 5 !A37/ "A9* IA37*+/

    5 C7/3;/,* 1J/0 U/.* J/); @ !A37/ "A9* IA37*+/

    @ C7/3;/,* 1J/0 Z1-M 5 !A37/ "A9* IA37*+/

    P C7/3;/,* J*1,*:*3/) @ Q*/+01 Q*/+01

    < C7/3;/,* 1J/0 0)/.*,*1+/3 5 (;)9/+0M/,0;0* (;)9/+0M/,0;0*

    R C7/3;/,* ,;-3A:A+ F -/+4/+

    ?;+4,*1+/3

    5 (;)9/+0M/,0;0* (;)9/+0M/,0;0*

    $ DU*/+ 5 !A37/ "A9* IA37*+/

  • 7/24/2019 Mata Kuliah Kekhususan Farmakologi-rev13Agustus2015

    8/12

    !"#" %&'(") N !*#151'12( &8( +'(-(+ 5"- TUL

    %15* !% N !"#$%#"%

    6%6 N @%11/5(-"#1/ !% N ,*0*,#*/ 2"-8(' N C*Q( 6*'O(-"

    ,*0*,#*/ 2*-": N D-22(

    31 >1:(+ R&0'")

    R"0

    L*-2"8"/

    7,*0 2"-8('9

    L*-2"8"/

    7,*0 2*-":9

    & (A+4/+0/) ./+ .*,/*+ ;U* 23*+*2 @ Q*/+01 Q*/+01

    5 \A,/) ,/:-A3 ./+ 3/0*T/+ @ B+44* B+44*

    @ Q/+.1:*,/,* ./+ 3/0*T/+ & L+,0*/0M L+,0*/0M

    @ E1+0)13 ./+ 2A0A),/:/)/+ & "A9* IA37*+/ "A9* IA37*+/

    P "/0/ ./+ :/+/UA:A+ ./3/: DE 5 !A37/ L+,0*/0M

    < B+/3*,*, ./0/ ./+ *+0A)-)A0/,*

    T/,*3 DE

    @ !A37/ !A37/

    R (A+M;,;+/+ -)101Z13 DE F

    3/0*T/+

    @ !A37/ Q*/+01

    $ \*/, ./+ Z1+?1;+.*+4 ./3/: DE 5 (;)9/+0M/,0;0* B+44*

    % QA4;3/,* DE .* L+.1+A,*/ 5 (;)9/+0M/,0;0* >/?)*/3.*

    N "A23/)/,* ^A3,*+2* & >/?)*/3.* B+44*

    ()*+,*- LH^XGH( ./+ E1:*,* C0*2 5 >/?)*/3.* B+44*

    (A+A3*0* 5 "A9* IA37*+/ B+44*&& L+?1):/,* ;+0;2 Z/31+ ,;JMA2 ./+

    3/0*T/+

    @ (;)9/+0M/,0;0* Q*/+01

    &< DU*/+ & 5 "A9* IA37*+/ B+44*

    &R DU*/+ 5 5 "A9* IA37*+/ B+44*

  • 7/24/2019 Mata Kuliah Kekhususan Farmakologi-rev13Agustus2015

    9/12

  • 7/24/2019 Mata Kuliah Kekhususan Farmakologi-rev13Agustus2015

    10/12

    !"#" %&'(") N ."/0"+12*-10(+ ;

    %15* !% N !"#$%#"N

    6%6 N @%11/5(-"#1/ !% N ,*0*,#*/ 2"-8('N G-,#("#W

    ,*0*,#*/ 2*-":N !*'O"

    31 >1:(+ R&0'")

    R"0

    L*-2"8"/

    7,*0 2"-8('9

    L*-2"8"/

    7,*0 2*-":9

    & (A+4/+0/) ?/):/214A+1:*2 5 =)/+, =)/+,

    5 =/):/214A+1:*2 -/./ )A,A-01) 5 L+,0*/0M !A37/

    @ =/):/214A+1:*2 -/./ A+a*:

    :A0/J13*,:A

    5 L+,0*/0M Q*/+01

    P =/):/214A+1:*2 -/./ 0)/+,-1)0A)

    :A:J)/+A

    5 L+,0*/0M !A37/

    < (A)/+ ?/):/214A+1:*2 -/./

    -A+A:;/+ ./+ -A+4A:J/+4/+ 1J/0

    5 =)/+, =)/+,

    R B-3*2/,* ?/):/214A+1:*2 ./3/:

    ?/):/210A)/-*

    5 L+,0*/0M Q*/+01

    $ KA2+*2 3/J1)/01)*;: ./3/:

    ?/):/214A+1:*2

    5 L+,0*/0M !A37/

    % DU*/+ 5 L+,0*/0M !A37/

    !"#" %&'(") N L*-*0&"- 5"- L*-2*0

  • 7/24/2019 Mata Kuliah Kekhususan Farmakologi-rev13Agustus2015

    11/12

  • 7/24/2019 Mata Kuliah Kekhususan Farmakologi-rev13Agustus2015

    12/12

    !"#" %&'(") N =-51+/(-1S"/0"+1'12( ;

    %15* !% N !"#$%#"&&R

    6%6 N @

    %11/5(-"#1/ !% N ,*0*,#*/ 2"-8(' N G-,#("#W,*0*,#*/ 2*-": N C*Q( 6*'O(-"

    31 >1:(+ R&0'")

    R"0

    L*-2"8"/

    7,*0 2"-8('9

    L*-2"8"/

    7,*0 2*-":9

    & ^1):1+ 2A3/:*+ ./+

    21+0)/,A-,* T1):1+/3

    P "A9* IA37*+/ "A9* IA37*+/

    5 L+,;3*+ ./+ /+0*.*/JA0*2 1)/3 P Q*/+01 Q*/+01

    @ K*)1*.` /+0*0*)1*. 5 6*7*/+ 6*7*/+

    P SJ/0 M/+4 :A:-A+4/);T*

    :A0/J13*,:A 0;3/+4

    5 6*7*/+ 6*7*/+

    < E1)0*21,0A)1*. 5 (;)9/+0M/,0;0* (;)9/+0M/,0;0*

    R DU*/+ 5 "A9* IA37*+/ 6*7*/+

    !"#" %&'(") N ."/0"+1'12( %*01#*/":*(+ 5"- K(1#*/":*(+ ;

    %15* !% N !"#$%#"&&$

    6%6 N @

    %11/5(-"#1/ !% N ,*0*,#*/ 2"-8(' N !*'O"

    ,*0*,#*/ 2*-": N V(O("-

    31 >1:(+ R&0'")

    R"0

    L*-2"8"/

    7,*0 2"-8('9

    L*-2"8"/

    7,*0 2*-":9

    & E/+2A) ./+ :1./3*0/, 0A)/-* -/./

    2/+2A)

    5 >/?)*/3.* >/?)*/3.*

    5 B+0*2/+2A) 21+7A+,*1+/3 @ >/?)*/3.* >/?)*/3.*@ \*10A)/-A;0*2 ./+ 0A)/-* 0/)4A0 @ !A37/ 6*7*/+

    P !A2/+*,:A )A,*,0A+,* ,A3 2/+2A)

    0A)T/./- 2A:10A)/-*

    5 !A37/ 6*7*/+

    < C?A2 ,/:-*+4 ./+ 012,*,*0/, /+0*2/+2A) 5 8/9/*:;3* 8/9/*:;3*

    R (A+4A:J/+4/+ 1J/0 /+0*2/+2A) J/); 5 !A37/ 6*7*/+

    $ DU*/+ 5 !A37/ 6*7*/+